The European Commission plans to enhance the traceability of medical devices and monitoring of notification bodies to prevent the placing on the market of defective devices, like the adulterated breast implants produced by the firm PIP. On the other...
Identification
Bonjour, l'accès à cet article est réservé aux abonnés. Veuillez vous identifier dans le cadre ci-dessous.
MEPs back quotas for corporate boards, says EP committee chair - 11/04/2012
Social partners divided over EU action - 11/04/2012
Pharmaceutical industry spends 40 mn euro on lobbying - 05/04/2012
Employers oppose directive on musculoskeletal disorders - 05/04/2012
Cigarettes: Neutral packaging still an option - 05/04/2012
MEPs back quotas for corporate boards, says EP committee chair - 
